Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 109
of 6Next
1:

Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways.

Lu Q, Lin X, Feng J, Zhao X, Gallagher R, Lee MY, Chiao JW, Liu D.

J Hematol Oncol. 2008 Jun 9;1:6.

PMID: 18577263 [PubMed - in process]

2:

[Effect of phenylhexyl isothiocyanate on inducing apoptosis of multiple myeloma cells in vitro]

Lu QY, Wang Z, Liu DL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):89-92. Chinese.

PMID: 18315907 [PubMed - in process]

3:

Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells.

Ma X, Fang Y, Beklemisheva A, Dai W, Feng J, Ahmed T, Liu D, Chiao JW.

Int J Oncol. 2006 May;28(5):1287-93.

PMID: 16596246 [PubMed - indexed for MEDLINE]

4:

[Experiment study of PHI on histone methylation and acetylation in Molt-4 cells]

Huang YQ, Ma XD, Zhen RJ, Chiao JW, Liu DL.

Zhonghua Xue Ye Xue Za Zhi. 2007 Sep;28(9):612-5. Chinese.

PMID: 18246819 [PubMed - in process]

5:

Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells.

Beklemisheva AA, Fang Y, Feng J, Ma X, Dai W, Chiao JW.

Anticancer Res. 2006 Mar-Apr;26(2A):1225-30.

PMID: 16619528 [PubMed - indexed for MEDLINE]

6:

Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.

Lee EJ, Lee BB, Kim SJ, Park YD, Park J, Kim DH.

Int J Oncol. 2008 Oct;33(4):767-76.

PMID: 18813790 [PubMed - indexed for MEDLINE]

7:

Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.

Liu S, Cheng H, Kwan W, Lubieniecka JM, Nielsen TO.

Mol Cancer Ther. 2008 Jun;7(6):1751-61.

PMID: 18566246 [PubMed - indexed for MEDLINE]

8:

Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.

Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M.

J Urol. 2008 Sep;180(3):1131-6. Epub 2008 Jul 18.

PMID: 18639283 [PubMed - indexed for MEDLINE]

9:

Bmf contributes to histone deacetylase inhibitor-mediated enhancing effects on apoptosis after ionizing radiation.

Zhang Y, Adachi M, Kawamura R, Zou HC, Imai K, Hareyama M, Shinomura Y.

Apoptosis. 2006 May 30. [Epub ahead of print]

PMID: 16738812 [PubMed - as supplied by publisher]

10:

HDAC4 promotes growth of colon cancer cells via repression of p21.

Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, Mariadason JM.

Mol Biol Cell. 2008 Oct;19(10):4062-75. Epub 2008 Jul 16.

PMID: 18632985 [PubMed - indexed for MEDLINE]

11:

Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells.

Susick L, Veluthakal R, Suresh MV, Hadden T, Kowluru A.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1571-83. Epub 2007 Dec 5.

PMID: 18053091 [PubMed - in process]

12:

Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.

Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.

Int J Mol Med. 2008 Nov;22(5):605-11.

PMID: 18949380 [PubMed - in process]

13:

Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter.

Nian H, Delage B, Pinto JT, Dashwood RH.

Carcinogenesis. 2008 Sep;29(9):1816-24. Epub 2008 Jul 14.

PMID: 18628250 [PubMed - indexed for MEDLINE]

14:

Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.

Law AY, Lai KP, Lui WC, Wan HT, Wong CK.

Exp Cell Res. 2008 Oct 1;314(16):2975-84. Epub 2008 Jul 9.

PMID: 18652825 [PubMed - indexed for MEDLINE]

15:

THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID ALTERS GROWTH PROPERTIES OF RENAL CELL CARCINOMA IN VITRO AND IN VIVO.

Jones J, Juengel E, Mickuckyte A, Hudak L, Wedel S, Jonas D, Blaheta RA.

J Cell Mol Med. 2008 Jul 24. [Epub ahead of print]

PMID: 18657224 [PubMed - as supplied by publisher]

16:

[Apoptosis of multiple myeloma cells induced by 8-Cl-cAMP in vitro]

Cheng YM, Zhu Q, Jia PM, Hu JP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Dec;15(6):1204-7. Chinese.

PMID: 18088467 [PubMed - in process]

17:

Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A.

Crabb SJ, Howell M, Rogers H, Ishfaq M, Yurek-George A, Carey K, Pickering BM, East P, Mitter R, Maeda S, Johnson PW, Townsend P, Shin-ya K, Yoshida M, Ganesan A, Packham G.

Biochem Pharmacol. 2008 Aug 15;76(4):463-75. Epub 2008 Jun 20.

PMID: 18611394 [PubMed - indexed for MEDLINE]

18:

[Phenylhexyl Isothiocyanate Reducing U266 Cell Line Methylation Level of p16 Gene.]

Chen BA, Shou BM, Zhou DR, Ding JH, Gao C, Sun YY, Wang J, Chen J, Zhao G, Song HH, Bao W, Liu DL, Ma XD, Lu ZH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Oct;16(5):1060-3. Chinese.

PMID: 18928595 [PubMed - in process]

19:

[Apoptosis of multiple myeloma RPMI8226 cell line induced by matrine]

Yang JJ, Gao SM, Chen H.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Jun;15(3):515-8. Chinese.

PMID: 17605856 [PubMed - in process]

20:

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.

Dejligbjerg M, Grauslund M, Litman T, Collins L, Qian X, Jeffers M, Lichenstein H, Jensen PB, Sehested M.

Mol Cancer. 2008 Sep 12;7:70.

PMID: 18789133 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 109
of 6Next